# The Need for AI Integration

### **Challenges in Early Gastrointestinal Cancer Detection**

Despite advancements in medical imaging and endoscopy, early detection of stomach and colorectal cancer remains a **major challenge** due to limitations in current diagnostic methods.

#### **Key Limitations of Current Gastrointestinal Cancer Diagnostics**

* **High Error Rate in Endoscopic Interpretation**
  * **33.6% misdiagnosis rate** in gastrointestinal endoscopic evaluations.
  * Many **early-stage abnormalities** go undetected due to the complexity of lesions and human error.
* **Long Asymptomatic Periods**
  * **Gastrointestinal cancers remain asymptomatic for up to 10 years**, delaying diagnosis.
  * By the time symptoms appear, cancer is often in an **advanced stage with poor survival rates**.
* **Low Survival Rates for Late-Stage Diagnosis**
  * If early detection fails, **stomach and colorectal cancer survival rates drop to 20-40%**.
  * Late detection leads to **increased treatment costs, reduced quality of life, and higher mortality**.

### **AI-Powered Solutions by Apex AI**

Artificial intelligence can revolutionize early cancer detection by enhancing endoscopic interpretation, reducing diagnostic errors, and enabling proactive cancer monitoring.

#### **How AI Solves These Challenges**

* **AI-Driven Endoscopic Analysis with 90%+ Accuracy**
  * Machine learning models improve endoscopic imaging interpretation, significantly reducing **false negatives and misdiagnoses.**
  * Real-time AI assistance helps doctors detect **subtle, early-stage abnormalities** more effectively.
* **Continuous Monitoring and Risk Prediction**
  * AI enables **longitudinal tracking** of precancerous lesions, identifying **high-risk patients before cancer develops**.
  * This proactive approach reduces the **10-year diagnostic delay**, allowing **earlier interventions**.
* **Drastically Improved Survival Rates with Early Diagnosis**
  * **Stomach cancer:** 96.9% survival rate with early detection.
  * **Colorectal cancer:** 93.8% survival rate with early detection.
  * AI-powered screening helps ensure timely and life-saving interventions.

### **Why AI is the Future of Cancer Diagnostics**

By integrating AI into gastrointestinal cancer screening, Apex AI aims to bridge the gap between medical imaging limitations and real-world clinical needs. Our AI-driven endoscopic analysis platform has the potential to become a standard tool in global cancer prevention, improving survival rates, reducing costs, and optimizing patient outcomes.


---

# Agent Instructions: Querying This Documentation

If you need additional information that is not directly available in this page, you can query the documentation dynamically by asking a question.

Perform an HTTP GET request on the current page URL with the `ask` query parameter:

```
GET https://docs.apex-ai.ai/business-overview/publish-your-docs-1.md?ask=<question>
```

The question should be specific, self-contained, and written in natural language.
The response will contain a direct answer to the question and relevant excerpts and sources from the documentation.

Use this mechanism when the answer is not explicitly present in the current page, you need clarification or additional context, or you want to retrieve related documentation sections.
